Results 101 to 110 of about 1,312,400 (160)

Biomarkers in Spinocerebellar Ataxias. [PDF]

Cerebellum
Klockgether T, Grobe-Einsler M, Faber J.
europepmc   +1 more source

Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General Population. [PDF]

Liver Int
van Son KC, de Jong JCBC, Özsezen S, Caspers MPM, Augustijn QJJ, Snabel J, Galenkamp H, Hamer HM, van Dijk AM, van Koppen A, Mak AL, van den Born BJ, Nieuwdorp M, Drenth JPH, Gluud LL, Tushuizen ME, Hanemaaijer R, Verschuren L, Holleboom AG.   +18 more
europepmc   +1 more source

Anticipating the Future in an Uncertain Present: How Individuals Living With Medically Unexplained Cognitive Complaints Value Biomarker-Based Prognostics. [PDF]

Health Expect
van der Meer AF, Knippenberg M, Visser D, Boenink M.   +3 more
europepmc   +1 more source

Annual level changes of serum neuronal and glial biomarkers in a German professional football club. [PDF]

J Neurol
Marshall R, Abu-Rumeileh S, Habeck L, Steinacker P, Foschi M, Wohlfahrt K, Schwesig R, Riepenhof H, Droste JN, Barba L, Otto M.   +10 more
europepmc   +1 more source

Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation. [PDF]

World J Transplant
Lulic I, Lulic D, Pavicic Saric J, Bacak Kocman I, Rogic D.   +4 more
europepmc   +1 more source

New and Emerging Biomarkers in Chronic Kidney Disease. [PDF]

Biomedicines
Dopierała M, Nitz N, Król O, Wasicka-Przewoźna K, Schwermer K, Pawlaczyk K.   +5 more
europepmc   +1 more source

Editorial: Cancer biomarkers: molecular insights into diagnosis, prognosis, and risk prediction. [PDF]

Front Mol Biosci
Becatti M, Zheng S, Bronte G.
europepmc   +1 more source

The heterogeneous expression patterns of serum tumor markers in non-small cell lung cancer patients are predictive factors for progression-free survival. [PDF]

Discov Oncol
Li S, Zeng Z, Hong Z, Li J, Xie C.
europepmc   +1 more source

Methodologies for the Emulation of Biomarker-Guided Trials Using Observational Data: A Systematic Review. [PDF]

J Pers Med
Baldwin FD, Khalaf RKS, Kolamunnage-Dona R, Jorgensen AL.   +3 more
europepmc   +1 more source

Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2. [PDF]

Mol Med
Ngo KJ, Wong DY, Huang AY, Lee H, Nelson SF, Fogel BL.   +5 more
europepmc   +1 more source